Cargando…
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity
Most drugs used to treat viral disease target a virus-coded product. They inhibit a single virus or virus family, and the pathogen can readily evolve resistance. Host-targeted antivirals can overcome these limitations. The broad-spectrum activity achieved by host targeting can be especially useful i...
Autores principales: | Roche, Kathryn L., Remiszewski, Stacy, Todd, Matthew J., Kulp, John L., Tang, Liudi, Welsh, Alison V., Barry, Ashley P., De, Chandrav, Reiley, William W., Wahl, Angela, Garcia, J. Victor, Luftig, Micah A., Shenk, Thomas, Tonra, James R., Murphy, Eain A., Chiang, Lillian W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266789/ https://www.ncbi.nlm.nih.gov/pubmed/37317966 http://dx.doi.org/10.1172/JCI158978 |
Ejemplares similares
-
Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity
por: Finley, Lydia W. S., et al.
Publicado: (2011) -
Sirtuin deacetylases in neurodegenerative diseases of aging
por: Herskovits, Adrianna Z, et al.
Publicado: (2013) -
Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
por: Langley, Brett, et al.
Publicado: (2013) -
Active nuclear import of the deacetylase Sirtuin-2 is controlled by its C-terminus and importins
por: Eldridge, Matthew J. G., et al.
Publicado: (2020) -
Sirtuins: Sir2-related NAD-dependent protein deacetylases
por: North, Brian J, et al.
Publicado: (2004)